Sanofi buys US flu vaccine maker Protein for $750 mln
French pharmaceuticals giant Sanofi, which is looking to boost its presence in biotechnology, said Tuesday it had agreed to buy the privately-owned US vaccines maker Protein Sciences for up to $750 million (658 million euros).
Jul 11, 2017
0
2